FDA Recall of Pocas International's Popping Boba RTD Peach Oolong Tea
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Pocas International Corp. is voluntarily recalling 370 cases of POPPING BOBA RTD PEACH OOLONG TEA due to a packaging integrity issue that may affect product quality.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 14, 2026 and geographically references United States and Canada. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Food.
What Happened
Pocas International Corp. is initiating a voluntary recall of its product due to a packaging integrity issue that may compromise product quality.
Which Products Are Affected
The affected product is POPPING BOBA RTD PEACH OOLONG TEA 12 X 13.8OZ. Approximately 370 cases are involved, distributed to the states of NY, VA, FL, MA, TX, LA, UT, CA, and Canada. The recall number is H-0633-2026.
What You Should Do
Consumers should contact Pocas International Corp. for further instructions, as details will be provided by the firm.
Why This Matters
This recall addresses potential quality issues to ensure product safety, impacting consumers in the specified regions.
Source
Attribution: FDA Recall Number H-0633-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (746 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to April 14, 2026.
Frequently Asked Questions
Common questions about this FDA recall.